Sanuwave Health Inc (SNWV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,457 | -5,101 | -27,259 | -17,804 | -13,552 |
| Depreciation Amortization | 1,750 | 1,080 | 4,462 | 2,388 | 1,269 |
| Accounts receivable | 733 | 804 | -395 | -345 | 218 |
| Accounts payable and accrued liabilities | -486 | -866 | 3,181 | 2,656 | 1,475 |
| Other Working Capital | 1,937 | 270 | 9,928 | 5,983 | 3,847 |
| Other Operating Activity | -5,678 | 681 | 3,674 | 616 | 1,494 |
| Operating Cash Flow | $-5,201 | $-3,132 | $-6,409 | $-6,506 | $-5,249 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 948 | 360 | -529 | -441 | -277 |
| Investing Cash Flow | $948 | $360 | $-529 | $-441 | $-277 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,070 | 2,940 | 3,043 | 2,993 | 2,421 |
| Debt Issued | N/A | N/A | 1,033 | 1,033 | N/A |
| Debt Repayment | -121 | -65 | -199 | -143 | N/A |
| Common Stock Issued | 100 | 100 | N/A | N/A | N/A |
| Other Financing Activity | 55 | -505 | 1,244 | 1,007 | 944 |
| Financing Cash Flow | $5,104 | $2,470 | $5,121 | $4,890 | $3,365 |
| Exchange Rate Effect | 14 | -4 | -1 | -53 | -12 |
| Beginning Cash Position | 619 | 619 | 2,437 | 2,437 | 2,437 |
| End Cash Position | 1,484 | 313 | 619 | 327 | 264 |
| Net Cash Flow | $865 | $-306 | $-1,818 | $-2,110 | $-2,173 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,201 | -3,132 | -6,409 | -6,506 | -5,249 |
| Capital Expenditure | 0 | 0 | -529 | -441 | -277 |
| Free Cash Flow | -5,201 | -3,132 | -6,938 | -6,947 | -5,526 |